|
[1]赵龙风.肝病的现代诊断与治疗[M].北京:中国医药科技出版社, 2001∶409.
|
|
[2]秦树林, 滑立伟.药物性肝病102例临床分析[J].中国新药杂志, 2001, 10 (6) ∶457-459.
|
|
[3]季慧范, 王永刚.腺苷蛋氨酸治疗慢性肝炎重度和慢性肝炎重型36例疗效观察[J].临床肝胆病杂志, 2003, 19 (2) ∶124.
|
|
[4]Conales F, Ochoa P, Rins C, et al.Inhibition of glutathiong synthesis in the liver leads o S-adenosyl-L-methionine synthetase reduc-tion[J].Hepatology, 1992, 14 (3) ∶528-533.
|
|
[5]侯世荣, 唐保元, 林厚基, 等.腺苷蛋氨酸治疗黄疸型病毒性肝炎111例[J].中华传染病杂志, 1999, 12 (2) ∶129-130.
|
|
[6]Watson WH, Zhao Y, chawla RK.S-adenosylmethionine attenuates the lipopoly saccharide-induced expression of the gene for tumour necrosis factoralpha[J].Biochem J.1999, 342 (1) ∶21-25.
|
|
[7]刘业云, 史罗明, 龚箐, 等.思美泰治疗药物性肝炎高胆红素血症疗效观察[J].临床医学, 2002, 22 (11) ∶8.
|
|
[8]Manzillo G, piccinino F, Surrenti C, et al.Multicentre double-blind placebo-controlled study of intravenous and oral S-adenosy-L-methionioe (SAMe) in cholestatic patients with liver disease[J].Drug Invest, 1992, 4 (suppl4) ∶90-100.
|